Minerva Surgical (UTRS) Stock Statistics & Valuation Metrics

Minerva Surgical has a market cap or net worth of $888.00. The enterprise value is $215.67M.

Minerva Surgical has 8,878,582 shares outstanding. The number of shares has decreased by -2.65% in one year.

Minerva Surgical’s return on equity (ROE) is -1.99 and return on invested capital (ROIC) is -54.35%.

The current PE Ratio of Minerva Surgical is -0.19. Minerva Surgical’s PEG ratio is <0.01.

In the last 12 months, Minerva Surgical had revenue of 50.29M and earned -34.11M in profits. Earnings per share was -23.68.

In the last 12 months, operating cash flow was -38.73M and capital expenditures -69.00K, giving a free cash flow of -38.80M billion.

Minerva Surgical pays an annual dividend of ―, resulting in a dividend yield of ―

Minerva Surgical upcoming earnings date is Nov 11, 2024, TBA Not Confirmed.

Minerva Surgical as a current ratio of 2.53, with Debt / Equity ratio of 231.01%

In the past 12 months, Minerva Surgical has paid 11.00K in taxes.

Minerva Surgical EV to EBITDA ratio is -1.95, with an EV/FCF ratio of -1.10.

Minerva Surgical has $11.13M in cash and marketable securities with $43.55M in debt, giving a net cash position of $32.43M billion.

Gross margin is 54.17%, with operating margin of -61.44%, and net profit margin of -67.83%.

The average price target for Minerva Surgical is ―, which is 11.43% higher than the current price. The consensus rating is ―